ALIVUS
Invest with MTF
Invest Now
Invest in Alivus Life Sciences with 3.18X leverage
Performance
- Low
- ₹923
- High
- ₹960
- 52 Week Low
- ₹819
- 52 Week High
- ₹1,225
- Open Price₹960
- Previous Close₹952
- Volume39,127
- 50 DMA₹911.95
- 100 DMA₹921.80
- 200 DMA₹946.55
Investment Returns
- Over 1 Month + 5.6%
- Over 3 Month + 0.96%
- Over 6 Month -0.58%
- Over 1 Year -22.8%
Smart Investing Starts Here Start SIP with Alivus Life Sciences for Steady Growth!
Alivus Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21
- PEG Ratio
- 0.9
- Market Cap Cr
- 11,407
- P/B Ratio
- 3.8
- Average True Range
- 34.67
- EPS
- 45.82
- Dividend Yield
- 0.5
- MACD Signal
- 9.34
- RSI
- 53.45
- MFI
- 63.81
Alivus Life Sciences Financials
Alivus Life Sciences Technicals
EMA & SMA
Current Price
₹929.40
-22.35
(-2.35%)
- Bearish Moving Average 7
- Bullish Moving Average 9
- 20 Day
- ₹921.07
- 50 Day
- ₹911.95
- 100 Day
- ₹921.80
- 200 Day
- ₹946.55
Resistance and Support
937.5
- R3 988.80
- R2 974.40
- R1 951.90
- S1 915.00
- S2 900.60
- S3 878.10
Alivus Life Sciences Corporate Actions - Bonus, Splits, Dividends
Alivus Life Sciences F&O
About Alivus Life Sciences
- NSE Symbol
- ALIVUS
- BSE Symbol
- 543322
- Managing Director & CEO
- Dr. Yasir Rawjee
- ISIN
- INE03Q201024
Similar Stocks to Alivus Life Sciences
Alivus Life Sciences FAQs
Alivus Life Sciences share price is ₹929 As on 12 February, 2026 | 01:14
The Market Cap of Alivus Life Sciences is ₹11407.1 Cr As on 12 February, 2026 | 01:14
The P/E ratio of Alivus Life Sciences is 21 As on 12 February, 2026 | 01:14
The PB ratio of Alivus Life Sciences is 3.8 As on 12 February, 2026 | 01:14
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.